Greenfern Industries Limited Ordinary Shares Company Details Registered Office: 127 Normanby Road, Normanby 4671 Postal Address: 127 Normanby Road, Normanby 4671 Telephone: +64-27-420-2476 Facsimile
A judgment is expected to be delivered on Thursday. The S&P/NZX 50 index declined 122.94 points or 1.03% to 11,759.15....
Pacific Edge’s shares jumped as much as 6.3% as investors wait for the cancer diagnostic company to reveal whether major US health insurance provider will keep using its bladder tests. The S&P/NZX 5
Cancer diagnostics business Pacific Edge will apply for a secondary listing on the Australian stock exchange and expects its shares to begin trading on ASX in September. The firm’s board said being
By Paul McBeth Nov. 20 (BusinessDesk) - Bethunes Investments shareholders will vote next month on a deal to use its NZX listing as a vehicle for freight and logistics firm Transport Investments Ltd to
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection
By Suze Metherell Aug. 27 (BusinessDesk) - New Zealand shares rose to a record as Pacific Edge won a contract with US healthcare provider Kaiser Permanente and Genesis Energy posted earnings that b
Pacific Edge shares fell 26% to 8.4 cents on Monday, but “all is not necessarily lost”, said Forsyth Barr analysts. A local coverage determination in the United States means the company will no lo
New Zealand Rugby is poised for its biggest structural change in 25 years of professionalism with the bulk of its income and expenses carved out into a subsidiary if the controversial Silver Lake deal
Pacific Edge is upbeat about the draft gapfill or reimbursement rates for its new Cxbladder Triage Plus test from the US Centres for Medicare and Medicaid Services. Gapfill prices are proposed reimbur
Pacific Edge chief executive Peter Meintjes is optimistic that the company can capitalise on its “first-mover advantage” despite its Cxbladder tests losing coverage in the US. Pacific Edge’s sui
The Asia Pacific Trust ("the Fund") is a unit trust, as defined in the Units Trust Act 1960.The beneficial interest in the Fund is divided into units, with each unit representing an equal interest in.
Marlin Global Limited 20/05/2022 $1.28 Warrants
Pacific Edge has been placed on a trade halt while it reviews draft gapfill or reimbursement rates for its new Cxbladder Triage Plus test from the US Centres for Medicare and Medicaid Services. “[It
Shares in cancer diagnostics company Pacific Edge are down 2.44% to $0.120 after another setback in the US market. The US District Court for the Middle District of Pennsylvania has determined that it.
Forsyth Barr and Jarden analysts have raised their target prices for exchange operator NZX following a 10% guidance lift. NZX Ltd said Monday it expects full-year 2024 operating earnings before inte
A judgment is expected to be delivered on Thursday. The S&P/NZX 50 index declined 122.94 points or 1.03% to 11,759.15....
By Paul McBeth Oct. 27 (BusinessDesk) - New Plymouth-based freight and logistics group Transport Investments Ltd plans to join the NZX through a backdoor listing via Bethunes Investment in a deal valu
Pacific Edge Limited is a cancer diagnostic company specialising in the discovery and commercialisation of diagnostic and prognostic tests for the better detection and management of cancer. The compan
New Zealand has attracted an uptick in interest from overseas investors considering infrastructure opportunities in the country in recent months, according to promoter agencies. The Government hosted.
Manawa Energy Limited Ordinary Shares Company Details Registered Office: 108 Durham Street, Tauranga 3110 Postal Address: 108 Durham Street, Tauranga 3110 Telephone: +64-27-582-6600 Facsimile: n/a Web
2 Cheap Cars Group Limited Ordinary Shares Company Details Registered Office: 102 Mays Road, Onehunga, Auckland 1061 Postal Address: 102 Mays Road, Onehunga, Auckland 1061 Telephone: 09-869-3330 Facsi
Pacific Edge is still working through the implications of the Medicare contractor decision that its suite of products do not meet the threshold for coverage under the US Social Security Act. Trading
Third party data: All data displayed on the FundSource pages (Data) on BusinessDesk has been sourced from an independent third party, FE Fundinfo. NZME and its related bodies corporate and affiliates (together NZME) do not make any representation as to the currency, fairness, accuracy, completeness or reliability of the Data. Nor will NZME have any liability to any person in relation to the use of or reliance on the Data.
No financial or investment advice: The Data is general information only. It is not financial product or investment advice or an investment recommendation, and has not been prepared taking into account the objectives, financial situation or needs of any person. Potential investors should seek their own independent advice from a qualified financial adviser prior to making an investment decision. NZME makes no recommendation in relation to, and accept no responsibility or ongoing liability for, any person’s investment decisions.
No offer: The Data is only to be accessed by New Zealand residents from within New Zealand, and may not be copied or distributed to any other person. The Data does not constitute an offer or solicitation to offer financial products or conduct investment business in New Zealand or any other jurisdiction.
No guarantee: Past performance information should not be relied upon as (and is not) a promise, representation, warranty or guarantee as to the past, present or future performance. NZME does not guarantee repayment of any capital or payment of any returns on capital invested in the investments referred to in the Data.
Missing data? All data comes from FE fundinfo. BusinessDesk can help you get your data loaded and updated. Email [email protected] for help.